Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CPXM1 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
mRNA | HSH2D | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-07 |
mRNA | SCAMP3 | CTRPv2 | pan-cancer | AAC | -0.19 | 4e-07 |
mRNA | ANK1 | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-07 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-07 |
mRNA | SDHB | CTRPv2 | pan-cancer | AAC | -0.18 | 5e-07 |
mRNA | SOCS2 | CTRPv2 | pan-cancer | AAC | 0.18 | 7e-07 |
mRNA | GNA15 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-06 |
mRNA | GLTSCR2 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
mRNA | FAM117A | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-06 |